Market by Therapeutic Application, Technology, Treatment Type, Product, Application, and Country | Forecast 2021-2028
As per Triton’s report, the
European stem cell market is likely to attain a CAGR of 7.75% in terms of
revenue through the projected years of 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries scrutinized in
this market include:
• The UK
• Spain
• Germany
• Italy
• France
• Russia
• Rest of Europe
In Germany, the number of
patients with dementia is anticipated to surge in the near future, further
augmenting the stem cell market’s progress. With the surge in the incidences of
neurological dementia, several companies are involved in the development of
novel effective stem cell therapies. Additionally, the German Stem Cell
Network’s target is to create interactions with the field of regenerative
medicines, further to launch innovative national and foreign research
activities and alliances. Thus, such developments are likely to propel the stem
cell market on a growth path.
The pharmaceutical and
healthcare sectors in Russia hold more significant potential for efficient stem
cell studies and clinical trials. Moreover, the rapid patient enrollment,
higher clinical trial participation, and favorable currency exchange rates, are
among the country’s strengths. Here, quick patient enrollment is a significant
factor in initial-stage trials that would permit rapid project inductions.
Hence, these aspects are anticipated to offer several new opportunities for the
stem cell market to achieve its expected growth across Russia.
In Italy, the investments in
R&D for the development of beneficial therapies for treating chronic
diseases, along with clinical trials for stem cell therapy, is likely to
proliferate in the near future, owing to the surge in the number of chronic
conditions. Moreover, the pandemic outbreak has led Italian Bioscience
Institute to develop a protocol for treating the virus, which is based on isolated
and extended mesenchymal stem cells. Therefore, these factors are expected to
offer lucrative opportunities for the stem cell market in Italy.
Miltenyi Biotec manufactures
cell labeling reagents, cell separation, and analysis tools and systems for clinical
processes. Its product portfolio entails MACS sample preparations, cell
separation, and cell culture and stimulations, and others. Moreover, the
company’s research focuses on immunology, stem cell research, and cancer, among
others. It has its operations across multiple regions, and has headquarter
based in Germany.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
STEM CELL MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON STEM CELL MARKET
2.3. KEY
IMPACT ANALYSIS
2.4. INDUSTRY
COMPONENTS
2.5. LEGAL,
POLICY, & REGULATORY FRAMEWORK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
INSIGHTS
2.9. MARKET
DRIVERS
2.9.1. GROWING
AWARENESS ABOUT UMBILICAL CORD STEM CELLS
2.9.2. SURGE
IN STEM CELL RESEARCH AND DEVELOPMENT
2.9.3. RISING
DEMAND FOR REGENERATIVE MEDICINE
2.10. MARKET RESTRAINTS
2.10.1. ETHICAL CONCERNS ASSOCIATED
WITH STEM CELLS
2.10.2. HIGH COST OF STEM CELL
PROCEDURES
2.10.3. STRINGENT REGULATIONS IN TERMS
OF STEM CELL THERAPY
2.11. MARKET OPPORTUNITIES
2.11.1. ADVANCEMENT IN TECHNOLOGY
2.11.2. RISK OF ADVERSE IMMUNE
REACTIONS AND COMPLICATIONS
3. EUROPE
STEM CELL MARKET OUTLOOK - BY THERAPEUTIC APPLICATION
3.1. NEUROLOGICAL
DISORDERS
3.2. ONCOLOGY
DISORDERS
3.3. DIABETES
3.4. INJURIES
AND WOUNDS
3.5. ORTHOPEDIC
TREATMENTS
3.6. CARDIOVASCULAR
DISORDERS
3.7. OTHER
THERAPEUTIC APPLICATIONS
4. EUROPE
STEM CELL MARKET OUTLOOK - BY TECHNOLOGY
4.1. CRYOPRESERVATION
4.2. ACQUISITION
4.2.1. STEM
CELL APHERESIS
4.2.2. STEM
CELL BONE MARROW MARKET
4.2.3. STEM
CELL UMBILICAL CORD
4.3. EXPANSION
AND SUB-CULTURE
4.4. PRODUCTION
4.4.1. STEM
CELL CULTURE
4.4.2. THERAPEUTIC
CLONING
4.4.3. IVF
5. EUROPE
STEM CELL MARKET OUTLOOK - BY TREATMENT TYPE
5.1. ALLOGENEIC
STEM CELL THERAPY
5.2. AUTOLOGIC
STEM CELL THERAPY
5.3. SYNGENEIC
STEM CELL THERAPY
6. EUROPE
STEM CELL MARKET OUTLOOK - BY PRODUCT
6.1. ADULT
STEM CELL
6.1.1. HEMATOPOIETIC
STEM CELL
6.1.2. NEURAL
STEM CELL
6.1.3. UMBILICAL
CORD STEM CELL
6.1.4. MESENCHYMAL
STEM CELL
6.1.5. DENTAL
STEM CELL
6.2. HUMAN
EMBRYONIC STEM CELL
6.3. PLURIPOTENT
6.4. MOUSE/RAT
NEURAL
7. EUROPE
STEM CELL MARKET OUTLOOK - BY APPLICATION
7.1. REGENERATIVE
MEDICINE
7.2. DRUG
DISCOVERY AND DEVELOPMENT
8. GEOGRAPHICAL
ANALYSIS - EUROPE
8.1. COUNTRY
ANALYSIS
8.1.1. GERMANY
8.1.2. FRANCE
8.1.3. UNITED
KINGDOM
8.1.4. ITALY
8.1.5. RUSSIA
8.1.6. SPAIN
8.1.7. REST
OF EUROPE
9. COMPANY
PROFILES
9.1. CORNING
INC
9.2. STEMCELL
TECHNOLOGIES
9.3. STRYKER
CORPORATION
9.4. BECTON
DICKINSON AND COMPANY (BD)
9.5. CYTORI
THERAPEUTICS
9.6. QIAGEN
NV
9.7. GE
HEALTHCARE
9.8. TAKARA
HOLDINGS INC
9.9. SMITH
& NEPHEW PLC
9.10. INTERNATIONAL STEM CELL CORP
9.11. MILTENYI BIOTEC
9.12. MERCK KGAA (SIGMA ALDRICH)
9.13. THERMO FISHER SCIENTIFIC INC
9.14. ALLCELLS LLC
9.15. PLURISTEM THERAPEUTICS INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH SCOPE &
DELIVERABLES
10.1.1. OBJECTIVES OF STUDY
10.1.2. SCOPE OF STUDY
10.2. SOURCES OF DATA
10.2.1. PRIMARY DATA SOURCES
10.2.2. SECONDARY DATA SOURCES
10.3. RESEARCH METHODOLOGY
10.3.1. EVALUATION OF PROPOSED MARKET
10.3.2. IDENTIFICATION OF DATA SOURCES
10.3.3. ASSESSMENT OF MARKET DETERMINANTS
10.3.4. DATA COLLECTION
10.3.5. DATA VALIDATION & ANALYSIS
TABLE 1 EUROPE STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 EUROPE STEM CELL MARKET, BY THERAPEUTIC APPLICATION,
2021-2028 (IN $ MILLION)
TABLE 4 EUROPE STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $
MILLION)
TABLE 5 EUROPE ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 6 EUROPE PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 7 EUROPE STEM CELL MARKET, BY TREATMENT TYPE, 2021-2028 (IN $
MILLION)
TABLE 8 EUROPE STEM CELL MARKET, BY PRODUCT, 2021-2028, (IN $
MILLION)
TABLE 9 EUROPE ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $
MILLION)
TABLE 10 EUROPE STEM CELL MARKET, BY APPLICATION,
2021-2028 (IN $ MILLION)
TABLE 11 EUROPE STEM CELL MARKET, BY COUNTRY,
2021-2028 (IN $ MILLION)
FIGURE 1 EUROPE STEM CELL MARKET 2021-2028 (IN $
MILLION)
FIGURE 2 EUROPE STEM CELL MARKET, BY NEUROLOGICAL
DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 3 EUROPE STEM CELL MARKET, BY ONCOLOGY
DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 4 EUROPE STEM CELL MARKET, BY DIABETES,
2021-2028 (IN $ MILLION)
FIGURE 5 EUROPE STEM CELL MARKET, BY INJURIES AND
WOUNDS, 2021-2028 (IN $ MILLION)
FIGURE 6 EUROPE STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS,
2021-2028 (IN $ MILLION)
FIGURE 7 EUROPE STEM CELL MARKET, BY CARDIOVASCULAR
DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 8 EUROPE STEM CELL MARKET, BY OTHER
THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 9 EUROPE STEM CELL MARKET, BY CRYOPRESERVATION,
2021-2028 (IN $ MILLION)
FIGURE 10 EUROPE STEM CELL MARKET, BY ACQUISITION,
2021-2028 (IN $ MILLION)
FIGURE 11 EUROPE STEM CELL MARKET, BY STEM CELL
APHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 12 EUROPE STEM CELL MARKET, BY STEM CELL BONE MARROW
MARKET, 2021-2028 (IN $ MILLION)
FIGURE 13 EUROPE STEM CELL MARKET, BY STEM CELL
UMBILICAL CORD, 2021-2028 (IN $ MILLION)
FIGURE 14 EUROPE STEM CELL MARKET, BY EXPANSION AND
SUB-CULTURE, 2021-2028 (IN $ MILLION)
FIGURE 15 EUROPE STEM CELL MARKET, BY PRODUCTION,
2021-2028 (IN $ MILLION)
FIGURE 16 EUROPE STEM CELL MARKET, BY STEM CELL
CULTURE, 2021-2028 (IN $ MILLION)
FIGURE 17 EUROPE STEM CELL MARKET, BY THERAPEUTIC
CLONING, 2021-2028 (IN $ MILLION)
FIGURE 18 EUROPE STEM CELL MARKET, BY IVF, 2021-2028
(IN $ MILLION)
FIGURE 19 EUROPE STEM CELL MARKET, BY ALLOGENEIC STEM
CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 20 EUROPE STEM CELL MARKET, BY AUTOLOGIC STEM
CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 21 EUROPE STEM CELL MARKET, BY SYNGENEIC STEM CELL
THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 22 EUROPE STEM CELL MARKET, BY ADULT STEM CELL,
2021-2028 (IN $ MILLION)
FIGURE 23 EUROPE STEM CELL MARKET, BY HEMATOPOIETIC
STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 24 EUROPE STEM CELL MARKET, BY NEURAL STEM CELL,
2021-2028 (IN $ MILLION)
FIGURE 25 EUROPE STEM CELL MARKET, BY UMBILICAL CORD
STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 26 EUROPE STEM CELL MARKET, BY MESENCHYMAL STEM
CELL, 2021-2028 (IN $ MILLION)
FIGURE 27 EUROPE STEM CELL MARKET, BY DENTAL STEM CELL,
2021-2028 (IN $ MILLION)
FIGURE 28 EUROPE STEM CELL MARKET, BY HUMAN EMBRYONIC
STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 29 EUROPE STEM CELL MARKET, BY PLURIPOTENT,
2021-2028 (IN $ MILLION)
FIGURE 30 EUROPE STEM CELL MARKET, BY MOUSE/RAT NEURAL,
2021-2028 (IN $ MILLION)
FIGURE 31 EUROPE STEM CELL MARKET, BY REGENERATIVE
MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 32 EUROPE STEM CELL MARKET, BY DRUG DISCOVERY
AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
FIGURE 33 GERMANY STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 34 FRANCE STEM CELL MARKET 2021-2028 (IN $
MILLION)
FIGURE 35 UNITED KINGDOM STEM CELL MARKET 2021-2028 (IN
$ MILLION)
FIGURE 36 ITALY STEM CELL MARKET 2021-2028 (IN $
MILLION)
FIGURE 37 RUSSIA STEM CELL MARKET 2021-2028 (IN $
MILLION)
FIGURE 38 SPAIN STEM CELL MARKET 2021-2028 (IN $
MILLION)
FIGURE 39 REST OF EUROPE STEM CELL MARKET 2021-2028 (IN
$ MILLION)